Unaudited Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Revenues
Product revenue, net	$ 109,085,000	$ 100,106,000	$ 214,735,000	$ 187,255,000
Collaboration revenue	892,000	398,000	1,729,000	398,000
Total revenues	109,977,000	100,504,000	216,464,000	187,653,000
Expenses
Cost of product revenue	(43,003,000)	(35,148,000)	(81,455,000)	(68,767,000)
Cost of collaboration revenue	(217,000)	(85,000)	(412,000)	(85,000)
Research and development	(50,614,000)	(61,625,000)	(111,343,000)	(116,270,000)
Selling, general, and administrative	(71,038,000)	(79,710,000)	(134,460,000)	(148,904,000)
Loss from operations	(54,895,000)	(76,064,000)	(111,206,000)	(146,373,000)
Interest income	8,843,000	9,330,000	17,449,000	18,988,000
Interest expenses	(1,262,000)	(492,000)	(2,449,000)	(605,000)
Foreign currency gains (losses)	2,837,000	(4,108,000)	3,488,000	(6,176,000)
Other income (expense), net	3,750,000	(8,943,000)	3,553,000	418,000
Loss before income tax	(40,727,000)	(80,277,000)	(89,165,000)	(133,748,000)
Income tax expense	0	0	0	0
Net loss	$ (40,727,000)	$ (80,277,000)	$ (89,165,000)	$ (133,748,000)
Loss per share - basic (in dollars per share)	$ (0.04)	$ (0.08)	$ (0.08)	$ (0.14)
Loss per share - diluted (in dollars per share)	$ (0.04)	$ (0.08)	$ (0.08)	$ (0.14)
Weighted-average shares used in calculating net loss per ordinary share - basic (in shares)	1,091,933,150	975,937,790	1,086,413,130	974,541,780
Weighted-average shares used in calculating net loss per ordinary share - diluted (in shares)	1,091,933,150	975,937,790	1,086,413,130	974,541,780